Questions around Athira CEO's research began to surface in 2016

Questions about research authored by Leen Kawas, the Athira Pharma CEO, surfaced in the scientific community since as early as 2016, the Business Journal has learned. The Bothell-based biotech revealed Thursday it had placed Kawas on temporary leave, pending a review of her doctoral research while at Washington State University, where she received a doctorate in molecular pharmacology in 2011. Controversy around Kawas's work has been circulating through PubPe er, a site that allows users to discuss…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news